TCG Advisors’s Boston Scientific BSX Stock Holding History

TCG Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-172	Closed	-$7K	–	148
2019 Q2	$7K	Hold	172	–	–	0.01%	278
2019 Q1	$7K	Buy	+172	New	+$6.57K	0.01%	299

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

TCG Advisors's BSX Position: Q3 2019 in Review

TCG Advisors sold out of Boston Scientific (BSX) in Q3 2019, closing a stake of 172 shares — an estimated $7K sold.

TCG Advisors first reported a position in BSX in Q1 2019 and held it in 2 quarters. The position peaked at $7K in Q2 2019. 770 funds tracked by Wall St. Rank hold BSX as of Q3 2019.

TCG Advisors reported no remaining Boston Scientific position as of Q3 2019 after selling out during the quarter.
TCG Advisors sold 172 Boston Scientific shares in Q3 2019, an estimated $7K.
TCG Advisors first reported a position in Boston Scientific in Q1 2019 and held it in 2 quarters.
TCG Advisors's Boston Scientific position peaked at $7K in Q2 2019.
770 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2019.

Based on TCG Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.